pharma · Juvenile Neuronal Ceroid Lipofuscinosis · PLYX
Polaryx Therapeutics
Polaryx Therapeutics patent portfolio — 0 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.
Paramus, USA HQ
2014 Founded
9 Employees
Public company Type
PLYX · NYSE Ticker
Company details
- Status
- Public
- HQ
- Paramus, USA
- Founded
- 2014
- Employees
- 9
- Programs
- 1
- Drugs
- 0
- Patents
- 0
Polaryx Therapeutics patents
0 pharmaceutical patents indexed for Polaryx Therapeutics. 0 expire within 24 months.
Polaryx Therapeutics has 0 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.
No patents matched
Frequently asked questions
How many patents does Polaryx Therapeutics have?
0 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do Polaryx Therapeutics patents expire?
0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.